Checked.be · Company dossierhttps://checked.be/en/c/rx-antwerpen-zuid-1005268705 · as of 18-11-2026
RX Antwerpen Zuid
ActivePrivate limited company · founded 2024 · active for 2 yearsPrins Boudewijnlaan 111, 2610 AntwerpKBO/BCE: BE 1005.268.705subsidiary of Hidden nameVisible after signing in
Save to list
Keep companies in your own lists to find and compare them later. All it takes is a free account.
Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,347 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 1,556 companies had the same profile as RX Antwerpen Zuid has now. Each dot stands for 4 companies, two years later.
91.4%
were still trading
3.8%
stopped another way
4.6%
went bankrupt
Micro
2 to 5 years old
negative equity
a small loss
Another 0.3% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,556 companies, not a prediction for RX Antwerpen Zuid. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Name after signing inVisible after signing in appointed as director
General meeting of 06-07-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1005268705
New establishment in Antwerp
Radiologie Mertens Bollen, Fruithoflaan 54
IncorporationName hiddenVisible after signing in, Hidden nameVisible after signing in (managing director) and Name after signing inVisible after signing in appointed · Registered office clause: Prins Boudewijnlaan 111, 2610 Antwerpen (district Wilrijk) · Founder: Name hiddenVisible after signing in · published on 30-01-2024 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as RX Antwerpen Zuid: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €662,000 and €824,000, founded between 2023 and 2024.
RX Antwerpen Zuid has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity of -€28,286 and a net result of -€31,286.
Its solvency ranks better than 5% of 21,347 sector peers (NACE 86) in financial year 2025.
The company number of RX Antwerpen Zuid is 1005.268.705. The VAT number is the same number with BE in front: BE 1005.268.705.
Where is RX Antwerpen Zuid based?
The registered office is at Prins Boudewijnlaan 111, 2610 Antwerp.Company details
What does RX Antwerpen Zuid do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of RX Antwerpen Zuid?
RX Antwerpen Zuid is a private limited company (BV).
When was RX Antwerpen Zuid founded?
RX Antwerpen Zuid was founded on 26-01-2024.
Is RX Antwerpen Zuid still active?
Yes, RX Antwerpen Zuid is an active enterprise in the KBO register.
How many employees does RX Antwerpen Zuid have?
RX Antwerpen Zuid had an average of 2.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of RX Antwerpen Zuid?
The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €302,487 and 31 comparable companies (NACE 86220). It probably lies between €400,000 and €630,000.
Is RX Antwerpen Zuid profitable?
In financial year 2025, RX Antwerpen Zuid made a loss of €31,286.
Where can I find the annual accounts of RX Antwerpen Zuid?
RX Antwerpen Zuid filed 1 annual account with the National Bank of Belgium, for financial year 2025.